A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis (Protocol # IM0271015 )(NCT06025578)

The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.

Learn More

Principal Investigator(s)

Caroline Gulati, MD


Bristol-Myers Squibb


Carolina Garavito at 203-358-8879 or [email protected]


SHMG- Pulmonary Associates
29 Hospital Plaza
Stamford, CT 06902

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.